INOFEA will participate at the 3rd Industrial Biocatalysis Symposium on June 4th, 2020 in Wädenswil, Switzerland
Each year the Competence Center for Biocatalysis hosts the Biocatalysis Symposium in Wädenswil. This event connects industry and academia with the intention to broaden the usage of biocatalytic enzymes.
INOFEA will participate at the 35th International Exhibition for Fine and Speciality Chemicals on 27-28 May 2020, Cologne, Germany
The Chemspec Europe is the key event for international trade and valuable networking within the fine and speciality chemicals industry. INOFEA will present the company and technology to demonstrate the possible use of enzzen®-enzymes for the chemical industry.
First Supply Agreement in Place
INOFEA has signed a supply agreement for enzzen®-enzymes with an international pharmaceutical company. The enzymes will be used for the development of a new drug.
INOFEA at the 4th European Chemistry Partnering in Frankfurt
INOFEA participates also in 2020 at the 4th ECP event in Frankfurt and we welcome you to meet with us on Feb. 27. We enjoy this event every year and meet a lot of interesting people and companies to explore mutual interest in business opportunities.
INOFEA is participating at the DECHEMA Conference: Enzymes for Industrial Applications
The 4th DECHEMA-PRAXISforum “Enzymes for Industrial Applications” offers industry professionals a platform to discuss the latest developments in enzyme technology and biocatalysis. It is a perfect platform to meet solution providers, key users of enzymes and learn about new products, services and process and production technologies. INOFEA participates with a booth, presenting the enzzen®- technology and we welcome you to meet with us in Frankfurt later this year.
INOFEA moves of Headquarter to BL
INOFEA has moved the headquarter from Basel-Stadt to Basel-Landschaft with the opportunity to move into a facility with lab and office space later in 2020. Our new location is directly in the neighbourhood of the University for Applied Sciences in Muttenz.
INOFEA’s Shareholders agreed to a Capital Increase
In an extraordinary shareholder meeting the shareholders of INOFEA agreed to a new financing round (Series B) to support the companies’ growth strategy.
INOFEA is visiting the Vaccine Congress in Barcelona from 29 – 31 Oct. 2019
Every year experts from the industry, academia and funding organizations meet in Barcelona to discuss the latest vaccine developments to fight infectious diseases. More than 800 participants discuss solutions to challenges around the political, commercial and scientific issues in manufacturing, clinical trials, strategy, regulation, veterinary vaccines, immune profiling, AMR, respiratory, influenza, therapeutic and emerging diseases. Come and meet with us to speak about the usage of INOFEA’s technology to improve the stability of vaccines.